Pamisell has ranked among the top searched stocks for 8 days in the past month.


As of 10:30 AM on the 16th, Pamisell is trading at 20,950 KRW, down 0.71% from the previous day. This represents a 34.29% increase compared to October 19. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.


Today, foreigners are tentatively recorded as net sellers of 3,000 shares. Over the past 5 days, individual investors have net purchased 180,974 shares, while foreigners and institutions have net sold 156,860 shares and net purchased 23,771 shares, respectively.




[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing